Fulcrum Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Fulcrum Asset Management's IDXX Position: Q2 2026 in Review
Fulcrum Asset Management increased its Idexx Laboratories (IDXX) stake by 1.7% in Q2 2026, buying an estimated $10.1K and bringing the position to 1,055 shares worth $565K. The position accounts for 0.06% of the portfolio, ranked #267.
Fulcrum Asset Management first reported a position in IDXX in Q2 2020 and has held it in 6 quarters since. The position peaked at $8.43M in Q2 2020. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Fulcrum Asset Management held 1,055 shares of Idexx Laboratories worth $565K as of Q2 2026.
- Fulcrum Asset Management bought 18 Idexx Laboratories shares in Q2 2026, an estimated $10.1K.
- Idexx Laboratories made up 0.06% of Fulcrum Asset Management's portfolio in Q2 2026, its #267 holding.
- Fulcrum Asset Management first reported a position in Idexx Laboratories in Q2 2020 and has held it in 6 quarters since.
- Fulcrum Asset Management's Idexx Laboratories position peaked at $8.43M in Q2 2020.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.